WIPR takes a look at what IP practitioners and commentators have said are some of the most influential court cases to have been decided over the last 12 months.
Association for Molecular Pathology et al v US Patent and Trademark Office et al
In a case widely-tipped to be heard by the US Supreme Court, the US Court of Appeals for the Federal Circuit held that DNA inventions could be patented.
The American Civil Liberties Union wanted pharmaceutical company Myriad Genetics’ patents for the BRCA1 and BRCA2 breast cancer genes to be invalidated because, it argued, they were incorrectly granted in terms of composition and method.
To continue reading, you need a subscription to WIPR. Start a subscription to WIPR for £455.
In-house feature articles, the archive and expert comment require a paid subscription. Subscribe now.
Want to give it a try? We are offering a two week free trial to the WIPR website – register and select “Free Trial” to begin access to the full WIPR archive and read the latest news, features and expert comment. Begin your free trial here.
Is your 2 week free trial about to end? Upgrade to a 12 month subscription for £455 now.
If you have already subscribed please login.
If you have any technical issues please email James Lynn on email@example.com.
2011, court decisions